Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb non-inferiority study of low-dose influenza vaccine with or without AS03 versus Fluarix in adults aged 60 years and older
2006-000939-97Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of low-dose influenza vaccine and Fluarix in influenza (3 arms), sponsored by GSK. Primary endpoints: Serum haemagglutination-inhibition antibody titre, Immunological non-inferiority of AS03-adjuvanted low-dose vaccine versus Fluarix and 1 more. Started Mar 2006; status: completed.
02
Drugs
low-dose influenza vaccineFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-000939-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000939-97.